Research publications

A portable organic plastic scintillator dosimetry system for low energy X-rays: a feasibility study using an intraoperative X-ray unit as the radiation source

Williams K, Robinson N, Trapp J, Ackerly T, Das R, Kemp P, Geso M

(2007), J Med Phys, 32(2), 73-6

15-Year biochemical relapse free survival in clinical Stage T1-T3 prostate cancer following combined external beam radiotherapy and brachytherapy; Seattle experience

Sylvester JE, Grimm PD, Blasko JC, Millar J, Orio PF 3rd, Skoglund S, Galbreath RW, Merrick G

(2007), Int J Radiat Oncol Biol Phys, 67(1), 57-64

Assessing mood and general health-related quality of life among men treated in Australia for localized prostate cancer

Newton F, Burney S, Frydenberg M, Millar J, Ng K

(2007), Int J Urol, 14(4), 311-6

Five-year outcomes after prostate seed implants for prostate cancer in Australia

Millar JL, Snow R, Royce P

(2007), Brachytherapy, 6(2), 107-8

Comparison of CT and positron emission tomography/CT coregistered images in planning radical radiotherapy in patients with non-small-cell lung cancer

Macmanus M, D'Costa I, Everitt S, Andrews J, Ackerly T, Binns D, Lau E, Ball D, Weih L, Hicks RJ

(2007), Australas Radiol, 51(4), 386-93

Long-term outcomes of patients with localized rectal cancer treated with chemoradiation or radiotherapy alone because of medical inoperability or patient refusal

Lim L, Chao M, Shapiro J, Millar JL, Kipp D, Rezo A, Fong A, Jones IT, McLaughlin S, Gibbs P

(2007), Dis Colon Rectum, 50(12), 2032-9

Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial

Dearnaley DP, Sydes MR, Graham JD, Aird EG, Bottomley D, Cowan RA, Huddart RA, Jose CC, Matthews JH, Millar J, Moore AR, Morgan RC, Russell JM, Scrase CD, Stephens RJ, Syndikus I, Parmar MK; RT01 collaborators

(2007), Lancet Oncol, 8(6), 475-87

An international multicenter study evaluating the impact of an alternative biochemical failure definition on the judgment of prostate cancer risk

Williams SG, Duchesne GM, Gogna NK, Millar JL, Pickles T, Pratt GR, Turner S

(2006), Int J Radiat Oncol Biol Phys, 65(2), 351-7

Management of glioma in Victoria (1998-2000): retrospective cohort study

Rosenthal MA, Drummond KJ, Dally M, Murphy M, Cher L, Ashley D, Thursfield V, Giles GG

(2006), Med J Aust, 184(6), 270-3

Does chemotherapy improve survival in high-risk stage I and II Merkel cell carcinoma of the skin?

Poulsen MG, Rischin D, Porter I, Walpole E, Harvey J, Hamilton C, Keller J, Tripcony L

(2006), Int J Radiat Oncol Biol Phys, 64(1), 114-9

Value of low-dose 2 x 2 Gy palliative radiotherapy in advanced low-grade non-Hodgkin's lymphoma

Ng M, Wirth A, Ryan G, MacManus M, Davis S

(2006), Australas Radiol, 50(3), 222-7

Disease-specific quality of life among patients with localized prostate cancer: an Australian perspective

Newton FJ, Burney S, Millar JL, Frydenberg M, Ng KT

(2006), BJU Int, 97(6), 1179-83

Alternative explanations for T-cell response to in-situ gene therapy for prostate cancer: in reply to Fujita et al. (Int J Radiat Oncol Biol Phys 2006;65:84-90)

Millar JL, Sutherland JS, Boyd RL.

(2006), Int J Radiat Oncol Biol Phys, 66(5), 1599

Management of muscle-invasive bladder cancer in Victoria, 1990-1995

Millar JL, Frydenberg M, Toner G, Syme R, Thursfield V, Giles GG; Urology Study Committee of the Victorian Co-operative Oncology Group

(2006), ANZ J Surg, 76(3), 113-9

A prospective phase II study of adjuvant postoperative radiation therapy following nodal surgery in malignant melanoma-Trans Tasman Radiation Oncology Group (TROG) Study 96.06

Burmeister BH, Mark Smithers B, Burmeister E, Baumann K, Davis S, Krawitz H, Johnson C, Spry N; Trans Tasman Radiation Oncology Group

(2006), Radiother Oncol, 81(2), 136-42

Cerebral radiation necrosis: incidence, outcomes, and risk factors with emphasis on radiation parameters and chemotherapy

Ruben JD, Dally M, Bailey M, Smith R, McLean CA, Fedele P

(2006), Int J Radiat Oncol Biol Phys, 65(2), 499-508

A simple technique for determining accurate urethral dosimetry after seed brachytherapy for prostate cancer

Millar JL, Longano AZ, Imbert SJ, Stokes D

(2006), Brachytherapy, 5(1), 27-31

Publication Details